TransCode Therapeutics, Inc.
USD5.04
-0.24 (-4.64%)
CEO
Philippe Calais
IPO Date
2021-07-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.25
Prev. Close
$5.29
Day Low
$3.85
Day High
$5.22
52W Low
$3.85
52W High
$20.99
Market Cap
$0.00B
Volume
2.32M
| $0.00 |
| 18 Jun 2024 | Calais Philippe | director | A-Award | Acquired | 70,000 | $1.20 |
| 18 Jun 2024 | Marquet Magda | director | A-Award | Acquired | 70,000 | $1.20 |
| 19 May 2023 | Calais Philippe | director | A-Award | Acquired | 45,000 | $0.28 |
| 19 May 2023 | Marquet Magda | director | A-Award | Acquired | 45,000 | $0.28 |
| 10 May 2023 | Calais Philippe | director | A-Award | Acquired | 9,500 | $0.30 |
| 10 May 2023 | Marquet Magda | director | A-Award | Acquired | 9,500 | $0.30 |
| 22 Jun 2022 | Calais Philippe | director: | A-Award | Acquired | 9,500 | $0.00 |
| 22 Jun 2022 | Marquet Magda | director: | A-Award | Acquired | 9,500 | $0.00 |